The bone niche of chondrosarcoma: A sanctuary for drug resistance, tumour growth and also a source of new therapeutic targets

Sarcoma

Volumn 2011, Issue , 2011, Pages

  Heymann, D ^a,b,c   David, E ^a,b   Blanchard, F ^a,b   Heymann, M F ^a,b,c   De Pinieux, G ^d,e   Gouin, F ^a,b,c   Redini F ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c HÔTEL DIEU   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS1 PROTEIN; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CELECOXIB; CHEMOKINE RECEPTOR CXCR4; CYCLOPHOSPHAMIDE; ENDOSTATIN; HISTONE DEACETYLASE 4; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MAMMALIAN TARGET OF RAPAMYCIN; ONCOSTATIN M; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; RANTES; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ZOLEDRONIC ACID;

ANGIOGENESIS; BONE MARROW TRANSPLANTATION; BONE NICHE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHONDROSARCOMA; CLINICAL EFFECTIVENESS; ENZYME ACTIVITY; HEMATOPOIETIC STEM CELL; HUMAN; HYPOXIA; LEUKEMIA; MULTIPLE MYELOMA; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; REVIEW; STEM CELL NICHE; TUMOR GROWTH;

EID: 80052668046     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2011/932451     Document Type: Review

References (85)

1. Boeuf S., Kunz P., Hennig T., Lehner B., Hogendoorn P. C. W., Bovée J. V. M. G., Richter W., A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma Journal of Pathology 2008 216 2 158 166
2. Bovée J. V. M. G., Cleton-Jansen A. M., Taminiau A. H. M., Hogendoorn P. C. W., Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment Lancet Oncology 2005 6 8 599 607 (Pubitemid 41051938)
3. Aigner T., Towards a new understanding and classification of chondrogenic neoplasias of the skeletonbiochemistry and cell biology of chondrosarcoma and its variants Virchows Archiv 2002 441 3 219 230
4. Gelderblom H., Hogendoorn P. C. W., Dijkstra S. D., Van Rijswijk C. S., Krol A. D., Taminiau A. H. M., Bovée J. V. M. G., The clinical approach towards chondrosarcoma Oncologist 2008 13 3 320 329 (Pubitemid 351679908)
5. De Pinieux G., Bouvier C., Heymann D., Recent advances in the biology of bone tumors and new diagnostic tools Bone Cancer 2010 chapter 19 New York, NY, USA Academic Press 225 234
6. Wittrant Y., Théoleyre S., Chipoy C., Padrines M., Blanchard F., Heymann D., Rédini F., RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis Biochimica et Biophysica Acta 2004 1704 2 49 57 (Pubitemid 39195349)
7. Meads M. B., Hazlehurst L. A., Dalton W. S., The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance Clinical Cancer Research 2008 14 9 2519 2526
8. Campanacci M., Bone and Soft Tissue Tumors 1999 2nd New York, NY, USA Springer
9. Lee F. Y., Mankin H. J., Fondren G., Gebhardt M. C., Springfield D. S., Rosenberg A. E., Jennings L. C., Chondrosarcoma of bone: an assessment of outcome Journal of Bone and Joint Surgery. Series A 1999 81 3 326 338 (Pubitemid 29153210)
10. Staals E.L., Palmerini E., Ferrari S., Mercuri M., Heymann D., Non-surgical treatment of chondrosarcoma: current concepts and future perspectives Bone Cancer 2010 chapter 31 New York, NY, USA Academic Press 375 383
11. Zhang J., Niu C., Ye L., Huang H., He XI., Tong W. G., Ross J., Haug J., Johnson T., Feng J. Q., Harris S., Wiedemann L. M., Mishina Y., Li L., Identification of the haematopoietic stem cell niche and control of the niche size Nature 2003 425 6960 836 841 (Pubitemid 37351467)
12. Calvi L. M., Adams G. B., Weibrecht K. W., Weber J. M., Olson D. P., Knight M. C., Martin R. P., Schipani E., Divieti P., Bringhurst F. R., Milner L. A., Kronenberg H. M., Scadden D. T., Osteoblastic cells regulate the haematopoietic stem cell niche Nature 2003 425 6960 841 846 (Pubitemid 37351468)
13. Arai F., Hirao A., Ohmura M., Sato H., Matsuoka S., Takubo K., Ito K., Koh G. Y., Suda T., Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche Cell 2004 118 2 149 161 (Pubitemid 38962572)
14. Nilsson S. K., Johnston H. M., Coverdale J. A., Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches Blood 2001 97 8 2293 2299 (Pubitemid 32291474)
15. Iwasaki H., Suda T., Cancer stem cells and their niche Cancer Science 2009 100 7 1166 1172
16. Basak G. W., Srivastava A. S., Malhotra R., Carrier E., Multiple myeloma bone marrow niche Current Pharmaceutical Biotechnology 2009 10 3 335 346
17. Lane S. W., Scadden D. T., Gilliland D. G., The leukemic stem cell niche: current concepts and therapeutic opportunities Blood 2009 114 6 1150 1157
18. Andersen T. L., Sondergaard T. E., Skorzynska K. E., Dagnaes-Hansen F., Plesner T. L., Hauge E. M., Plesner T., Delaisse J. M., A physical mechanism for coupling bone resorption and formation in adult human bone American Journal of Pathology 2009 174 1 239 247
19. Chang M. K., Raggatt L. J., Alexander K. A., Kuliwaba J. S., Fazzalari N. L., Schroder K., Maylin E. R., Ripoll V. M., Hume D. A., Pettit A. R., Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo Journal of Immunology 2008 181 2 1232 1244
20. Ito K., Hirao A., Arai F., Takubo K., Matsuoka S., Miyamoto K., Ohmura M., Naka K., Hosokawa K., Ikeda Y., Suda T., Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells Nature Medicine 2006 12 4 446 451
21. Hosokawa K., Arai F., Yoshihara H., Nakamura Y., Gomei Y., Iwasaki H., Miyamoto K., Shima H., Ito K., Suda T., Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction Biochemical and Biophysical Research Communications 2007 363 3 578 583 (Pubitemid 47513670)
22. Paget S., The distribution of secondary growths in cancer of the breast The Lancet 1889 133 3421 571 573
23. Yin T., Li L., The stem cell niches in bone Journal of Clinical Investigation 2006 116 5 1195 1201
24. Hosokawa K., Arai F., Yoshihara H., Iwasaki H., Nakamura Y., Gomei Y., Suda T., Knockdown of N-cadherin suppresses the long-term engraftment of hematopoietic stem cells Blood 2010 116 4 554 563
25. Clézardin P., Heymann D., Early bone metastasis-associated molecular and cellular events Bone Cancer 2010 chapter 3 New York, NY, USA Academic Press 41 45
26. Coghlin C., Murray G. I., Current and emerging concepts in tumour metastasis Journal of Pathology 2010 222 1 1 15
27. Perrot P., Rousseau J., Bouffaut A. -L., Rédini F., Cassagnau E., Deschaseaux F., Heymann M., Heymann D., Duteille F., Trichet V., Gouin F., Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence PLoS One 2010 5 6
28. Picci P., Sieberova G., Alberghini M., Balladelli A., Vanel D., Hogendoorn P. C.W., Mercuri M., Late sarcoma development after curettage and bone grafting of benign bone tumors European Journal of Radiology 2011 77 1 19 25
29. Demicheli R., Retsky M. W., Hrushesky W. J. M., Baum M., Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures Nature Clinical Practice Oncology 2007 4 12 699 710 (Pubitemid 350187005)
30. Demicheli R., Retsky M. W., Hrushesky W. J. M., Baum M., Gukas I. D., The effects of surgery on tumor growth: a century of investigations Annals of Oncology 2008 19 11 1821 1828
31. Grimaud E., Damiens C., Rousselle A. V., Passuti N., Heymann D., Gouin F., Bone remodelling and tumour grade modifications induced by interactions between bone and Swarm rat chondrosarcoma Histology and Histopathology 2002 17 4 1103 1111
32. Chanavaz M., The periosteum: the umbilical cord of bone. Quantification of the blood supply of cortical bone of periosteal origin Revue de Stomatologie et de Chirurgie Maxillo-Faciale 1995 96 4 262 267
33. Squier C. A., Ghoneim S., Kremenak C. R., Ultrastructure of the periosteum from membrane bone Journal of Anatomy 1990 171 233 239 (Pubitemid 20341330)
34. Zhang X., Awad H. A., O'Keefe R. J., Guldberg R. E., Schwarz E. M., A perspective: engineering periosteum for structural bone graft healing Clinical Orthopaedics and Related Research 2008 466 8 1777 1787
35. Sderstrm M., Bhling T., Ekfors T., Nelimarkka L., Aro H. T., Vuorio E., Molecular profiling of human chondrosarcomas for matrix production and cancer markers International Journal of Cancer 2002 100 2 144 151 (Pubitemid 34666187)
36. Boeuf S., Kunz P., Hennig T., Lehner B., Hogendoorn P. C. W., Bovée J. V. M. G., Richter W., A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma Journal of Pathology 2008 216 2 158 166
37. Diaz-Romero J., Romeo S., Bovée J. V. M. G., Hogendoorn P. C. W., Heini P. F., Mainil-Varlet P., Hierarchical clustering of flow cytometry data for the study of conventional central chondrosarcoma Journal of Cellular Physiology 2010 225 2 601 611
38. Fiorenza F., Abudu A., Grimer R. J., Carter S. R., Tillman R. M., Ayoub K., Mangham D. C., Davies A. M., Risk factors for survival and local control in chondrosarcoma of bone Journal of Bone and Joint Surgery. Series B 2002 84 1 93 99 (Pubitemid 34105631)
39. Lee F. Y., Mankin H. J., Fondren G., Gebhardt M. C., Springfield D. S., Rosenberg A. E., Jennings L. C., Chondrosarcoma of bone: An assessment of outcome Journal of Bone and Joint Surgery. Series A 1999 81 3 326 338 (Pubitemid 29153210)
40. Gitelis S., Bertoni F., Picci P., Campanacci M., Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli Journal of Bone and Joint Surgery. Series A 1981 63 8 1248 1257 (Pubitemid 11022301)
41. Kalinski T., Sel S., Kouznetsova I., Rpke M., Roessner A., Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors Pathology Research and Practice 2009 205 5 339 345
42. Kubo T., Sugita T., Shimose S., Matsuo T., Arihiro K., Ochi M., Expression of hypoxia-inducible factor-1 and its relationship to tumour angiogenesis and cell proliferation in cartilage tumours Journal of Bone and Joint Surgery. Series B 2008 90 3 364 370 (Pubitemid 351428956)
43. Lin C., McGough R., Aswad B., Block J. A., Terek R., Hypoxia induces HIF-1 and VEGF expression in chondrosarcoma cells and chondrocytes Journal of Orthopaedic Research 2004 22 6 1175 1181 (Pubitemid 39317905)
44. Ayala G., Liu C., Nicosia R., Horowitz S., Lackman R., Microvasculature and VEGF expression in cartilaginous tumors Human Pathology 2000 31 3 341 346 (Pubitemid 30161353)
45. McGough R. L., Lin C., Meitner P., Aswad B. I., Terek R. M., Angiogenic cytokines in cartilage tumors Clinical Orthopaedics and Related Research 2002 397 62 69 (Pubitemid 34442016)
46. Furumatsu T., Nishida K., Kawai A., Namba M., Inoue H., Ninomiya Y., Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth International Journal of Cancer 2002 97 3 313 322 (Pubitemid 34049021)
47. Nakagawa S. A., Lopes A., De Carvalho A. L., Rossi B. M., Da Cunha I. W., Soares F. A., Chung W. T., Alves L. A., Nitric oxide synthases, cyclooxygenase-2, nitrotyrosine, and angiogenesis in chondrosarcoma and their relation to prognosis Journal of Bone and Joint Surgery. Series A 2010 92 8 1738 1746
48. Boeuf S., Bovée J. V. M. G., Lehner B., Hogendoorn P. C. W., Richter W., Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours Histopathology 2010 56 5 641 651
49. Schioppa T., Uranchimeg B., Saccani A., Biswas S. K., Doni A., Rapisarda A., Bernasconi S., Saccani S., Nebuloni M., Vago L., Mantovani A., Melillo G., Sica A., Regulation of the chemokine receptor CXCR4 by hypoxia Journal of Experimental Medicine 2003 198 9 1391 1402 (Pubitemid 37392484)
50. Wang J., Wang J., Sun Y., Song W., Nor J. E., Wang C. Y., Taichman R. S., Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis Cellular Signalling 2005 17 12 1578 1592 (Pubitemid 41253997)
51. Kaplan R. N., Riba R. D., Zacharoulis S., Bramley A. H., Vincent L., Costa C., MacDonald D. D., Jin D. K., Shido K., Kerns S. A., Zhu Z., Hicklin D., Wu Y., Port J. L., Altorki N., Port E. R., Ruggero D., Shmelkov S. V., Jensen K. K., Rafii S., Lyden D., VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche Nature 2005 438 7069 820 827 (Pubitemid 41753060)
52. Sun X., Wei L., Chen Q., Terek R. M., CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression Molecular Cancer 2010 9, article no. 17
53. Lai T. H., Fong Y. C., Fu W. M., Yang R. S., Tang C. H., Stromal cell-derived factor-1 increase v 3 integrin expression and invasion in human chondrosarcoma cells Journal of Cellular Physiology 2009 218 2 334 342
54. Tang C. H., Yamamoto A., Lin Y. T., Fong YI. C., Tan T. W., Involvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis Biochemical Pharmacology 2010 79 2 209 217
55. Stier S., Ko Y., Forkert R., Lutz C., Neuhaus T., Grnewald E., Cheng T., Dombkowski D., Calvi L. M., Rittling S. R., Scadden D. T., Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size Journal of Experimental Medicine 2005 201 11 1781 1791 (Pubitemid 41002897)
56. Reichert J. C., Quent V. M. C., Burke L. J., Stansfield S. H., Clements J. A., Hutmacher D. W., Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment Biomaterials 2010 31 31 7928 7936
57. Chen Y. J., Wei Y. Y., Chen H. T., Fong YI. C., Hsu C. J., Tsai C. H., Hsu H. C., Liu S. H., Tang C. H., Osteopontin increases migration and MMP-9 up-regulation via v 3 integrin, FAK, ERK, and NF- B-dependent pathway in human chondrosarcoma cells Journal of Cellular Physiology 2009 221 1 98 108
58. Vincourt J. B., Etienne S., Cottet J., Delaunay C., Malanda B., Lionneton F., Sirveaux F., Netter P., Plénat F., Mainard D., Vignaud J. M., Magdalou J., C-propeptides of procollagens I 1 and II that differentially accumulate in enchondromas versus chondrosarcomas regulate tumor cell survival and migration Cancer Research 2010 70 11 4739 4748
59. Furumatsu T., Yamaguchi N., Nishida K., Kawai A., Kunisada T., Namba M., Inoue H., Ninomiya Y., Endostatin inhibits adhesion of endothelial cells to collagen I via integrin, a possible cause of prevention of chondrosarcoma growth Journal of Biochemistry 2002 131 4 619 626 (Pubitemid 34460618)
60. Rutkowski P., Kamiska J., Kowalska M., Ruka W., Steffen J., Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis Journal of Surgical Oncology 2003 84 3 151 159 (Pubitemid 37363158)
61. Kalinski T., Krueger S., Sel S., Werner K., Rpke M., Roessner A., ADAMTS1 is regulated by interleukin-1, not by hypoxia, in chondrosarcoma Human Pathology 2007 38 1 86 94 (Pubitemid 44880204)
62. Kerkel E., Bhling T., Herva R., Uria J. A., Saarialho-Kere U., Human macrophage metalloelastase (MMP-12) expression is induced in chondrocytes during fetal development and malignant transformation Bone 2001 29 5 487 493 (Pubitemid 33026470)
63. Yoon S. W., Chun J. S., Sung M. H., Kim J. Y., Poo H., -MSH inhibits TNF- -induced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor B signaling in human chondrosarcoma HTB-94 cells Osteoarthritis and Cartilage 2008 16 1 115 124
64. Yeh Y. Y., Chiao C. C., Kuo W. Y., Hsiao YU. C., Chen Y. J., Wei Y. Y., Lai T. H., Fong YI. C., Tang C. H., TGF- 1 increases motility and v 3 integrin up-regulation via PI3K, Akt and NF- B-dependent pathway in human chondrosarcoma cells Biochemical Pharmacology 2008 75 6 1292 1301
65. Fong Y. C., Li T. M., Wu C. M., Hsu S. F., Kao S. T., Chen R. J., Lin C. C., Liu S. C., Wu C. L., Tang C. H., BMP-2 increases migration of human chondrosarcoma cells via PI3K/Akt pathway Journal of Cellular Physiology 2008 217 3 846 855
66. David E., Guihard P., Brounais B., Riet A., Charrier C., Battaglia S., Gouin F., Ponsolle S., Bot R. L., Richards C. D., Heymann D., Rédini F., Blanchard F., Direct anti-cancer effect of oncostatin M on chondrosarcoma International Journal of Cancer 2011 128 8 1822 1835
67. Joyce J. A., Pollard J. W., Microenvironmental regulation of metastasis Nature Reviews Cancer 2009 9 4 239 252
68. Meads M. B., Hazlehurst L. A., Dalton W. S., The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance Clinical Cancer Research 2008 14 9 2519 2526
69. Konopleva M., Tabe Y., Zeng Z., Andreeff M., Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches Drug Resistance Updates 2009 12 4-5 103 113
70. Scotlandi K., Picci P., Kovar H., Targeted therapies in bone sarcomas Current Cancer Drug Targets 2009 9 7 843 853
71. Morioka H., Weissbach L., Vogel T., Nielsen G. P., Faircloth G. T., Shao LI., Hornicek F. J., Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis Clinical Cancer Research 2003 9 3 1211 1217 (Pubitemid 36323731)
72. Sutton K. M., Wright M., Fondren G., Towle C. A., Mankin H. J., Cyclooxygenase-2 expression in chondrosarcoma Oncology 2004 66 4 275 280 (Pubitemid 38822796)
73. Schrage Y. M., Machado I., Meijer D., Briaire-de Bruijn I., van den Akker B. E., Taminiau A. H. M., Kalinski T., Llombart-Bosch A., Bovée J. V. M. G., COX-2 expression in chondrosarcoma: a role for celecoxib treatment? European Journal of Cancer 2010 46 3 616 624
74. Sun X., Wei L., Chen Q., Terek R. M., HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity Journal of Biological Chemistry 2009 284 33 21881 21890
75. Blanchard F., Chipoy C., Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discovery Today 2005 10 3 197 204 (Pubitemid 40222231)
76. Sakimura R., Tanaka K., Yamamoto S., Matsunobu T., Li XU., Hanada M., Okada T., Nakamura T., Li Y., Iwamoto Y., The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells Clinical Cancer Research 2007 13 1 275 282 (Pubitemid 46121880)
77. Ory B., Moriceau G., Redini F., Heymann D., mTOR inhibitors (Rapamycin and its derivatives) and nitrogen containing bisphosphonates: bi-functional compounds for the treatment of bone tumours Current Medicinal Chemistry 2007 14 13 1381 1387 (Pubitemid 46902220)
78. Heymann D., Ory B., Gouin F., Green J. R., Rédini F., Bisphosphonates: new therapeutic agents for the treatment of bone tumors Trends in Molecular Medicine 2004 10 7 337 343 (Pubitemid 38881523)
79. Brown R. E., Brief communication: morphoproteomic portrait of the mTOR pathway in mesenchymal chondrosarcoma Annals of Clinical and Laboratory Science 2004 34 4 397 399 (Pubitemid 40040959)
80. Moriceau G., Ory B., Mitrofan L., Riganti C., Blanchard F., Brion R., Charrier C., Battaglia S., Pilet P., Denis M. G., Shultz L. D., Mnkknen J., Rédini F., Heymann D., Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (everolimus): pivotal role of the prenylation process Cancer Research 2010 70 24 10329 10339
81. Merimsky O., Bernstein-Molho R., Sagi-Eisenberg R., Targeting the mammalian target of rapamycin in myxoid chondrosarcoma Anti-Cancer Drugs 2008 19 10 1019 1021
82. Kollet O., Dar A., Shivtiel S., Kalinkovich A., Lapid K., Sztainberg Y., Tesio M., Samstein R. M., Goichberg P., Spiegel A., Elson A., Lapidot T., Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells Nature Medicine 2006 12 6 657 664 (Pubitemid 43865234)
83. Lai T. J., Hsu S. F., Li T. M., Hsu H. C., Lin J. G., Hsu C. J., Chou M. C., Lee M. C., Yang S. F., Fong YI. C., Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line Acta Pharmacologica Sinica 2007 28 8 1231 1235
84. Kubo T., Shimose S., Matsuo T., Tanaka K., Yasunaga Y., Sakai A., Ochi M., Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells Journal of Orthopaedic Research 2006 24 6 1138 1144 (Pubitemid 43870875)
85. Gouin F., Ory B., Rédini F., Heymann D., Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival International Journal of Cancer 2006 119 5 980 984 (Pubitemid 44116903)